Genetic characterization of Chinese hereditary non-polyposis colorectal cancer by DHPLC and multiplex PCR

Japanese Journal of Clinical Oncology

Volumn 34, Issue 11, 2004, Pages 660-666

  Yuan, Ying ^a   Huang, Yan Qing ^a   Cai, Shan Rong ^a   Song, Yong Mao ^a   Zheng, Shu ^a   Zhang, Su Zhan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hereditary non polyposis colorectal cancer (HNPCC); hMLH1 gene; hMSH2 gene point mutation; Large genomic deletions

Indexed keywords

GENOMIC DNA; PROTEIN MLH1; PROTEIN MLH2; TUMOR PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; DNA BINDING PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN MSH2;

ARTICLE; BLOOD SAMPLING; CHINESE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA SEQUENCE; FAMILIAL CANCER; GENE DELETION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MISSENSE MUTATION; NONSENSE MUTATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; ASIAN; BASE MISPAIRING; COLORECTAL TUMOR; FEMALE; GENETICS; MALE; MUTATION; PEDIGREE;

ASIAN CONTINENTAL ANCESTRY GROUP; BASE PAIR MISMATCH; CARRIER PROTEINS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; FEMALE; GERM-LINE MUTATION; HUMANS; MALE; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS;

EID: 16644382569     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyh121     Document Type: Article

References (35)

1. Park JG, Yuan Y. Genetic identification and management of hereditary nonpolyposis colorectal cancer (Review). Int J Oncol 1998;12:947-55.
2. Peltomaki P. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 2001;10:735-40.
3. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996;2:169-74.
4. Liu T, Van H, Kuismanen S, Percesepe A, Bisgaard ML, Pedroni M, et al. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res 2001;61:7798-802.
5. Wu Y, Berends MJ, Sijmons RH, Mensink RG, Verlind E, Kooi KA, et al. A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat Genet 2001;29:137-8.
6. Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 1998;17:2413-7.
7. Cunningham JM, Kim CY, Christensen ER, Tester DJ, Pare Y, Burgart LJ, et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 2001;69:780-90.
8. Beck NE, Tomlinson IP, Homfray T, Frayling I, Hodgson SV, Harocopos C, et al. Use of SSCP analysis to identify germline mutations in HNPCC families fulfilling the Amsterdam criteria. Hum Genet 1997;99: 219-24.
9. Wijnen J, Vasen H, Khan PM, Menko FH, van der Klift H, van Leeuwen C, et al. Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 1995;56: 1060-6.
10. Wahlberg S, Liu T, Lndblom P, Lindblom A. Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1. Genet Test 1999;3:259-64.
11. Holinski-Feder E, Muller-Koch Y, Friedl W, Moeslein G, Keller G, Plaschke J, et al. DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Methods 2001;47:21-32.
12. Wang Y, Friedl W, Lamberti C, Jungck M, Mathiak M, Pagenstecher C, et al. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Int J Cancer 2003;103:636-41.
13. Wijnen J, van der Klift H, Vasen H, Khan PM, Menko F, Tops C, et al. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 1998;20:326-8.
14. Charbonnier F, Olschwang S, Wang Q, Boisson C, Martin C, Buisine MP, et al. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res 2002;62:848-53.
15. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 1991;34:424-5.
16. Baba S. Clinical applications of genetic studies in hereditary colorectal cancer. In: Baba S, editor. New Strategies for Treatment of Hereditary Colorectal Cancer. Tokyo: Churchill Livingston 1996;137-52.
17. Yuan Y, Han HJ, Zheng S, Park JG. Germline mutations of hMLH1 and hMSH2 genes in patients with suspected hereditary nonpolyposis colorectal cancer and sporadic early onset colorectal cancer. Dis Colon Rectum 1998;41:434-40.
18. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 1997;89: 1758-62.
19. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453-6.
20. Yuan Y, Zhang SZ, Zheng S. Criteria for Chinese hereditary colon cancer. Chin J Oncol 2004;26:191-2.
21. Kurzawski G, Safranow K, Suchy J, Chlubek D, Scott RJ, Lubinski J. Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods 2002;51:89-100.
22. Cai SJ, Xu Y, Cai GX, Lian P, Guan ZQ, Mo SJ, et al. Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer. World J Gastroenterol 2003;9:284-7.
23. Song YM, Zheng S. Analysis for phenotype of HNPCC in China. World J Gastroenterol 2002;8:830-40.
24. Cai Q, Sun MH, Lu HF, Zhang TM, Mo SJ, Xu Y, et al. Clinicopathological and molecular genetic analysis of 4 typical Chinese HNPCC families. World J Gastroenterol 2001;7:805-10.
25. Cui L, Jin HY, Cheng HY, Yan YD, Meng RG, Yu, DH. Genetic detection of Chinese hereditary nonpolyposis colorectal cancer. World J Gastroenterol 2004;10:209-13.
26. Zhao B, Wang ZJ, Xu YF, Wan YL, Li P, Huang YT. Report of 16 kindreds and one kindred with hMLH1 germline mutation. World J Gastroenterol 2002;8:263-6.
27. Han HJ, Yuan Y, Ku JL, Oh JH, Won YJ, Kang KJ, et al. Germline mutations of h1MLH1 and hMSH2 genes in Korean hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst 1996;88:1317-9.
28. Miyaki M, Konishi M, Muraoka M, Kikuchi-Yanoshita R, Tanaka K, Iwama T, et al. Germ line mutations of hMSH2 and hMLH1 genes in Japanese families with hereditary nonpolyposis colorectal cancer (HNPCC): usefulness of DNA analysis for screening and diagnosis of HNPCC patients. J Mol Med 1995;73:515-20.
29. Yuan Y, Zheng S. Mutations of hMLH1 and hMSH2 genes in suspected hereditary nonpolyposis colorectal cancer. Natl Med J China 1999;79:346-8.
30. Park JG, Vasen HFA, Park KJ, Peltomaki P, Ponz de Leon M, Rodriguez-Bigas MA, et al. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on hereditary nonpolyposis colorectal cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum 1999;42:710-6.
31. Charbonnier F, Raux G, Wang Q, Drouot N, Cordier F, Limacher JM, et al. Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res 2000;60:2760-3.
32. Nystrom-Lahti M, Kristo P, Nicolaides NC, Chang SY, Aaltonen LA, Moisio AL, et al. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1995;1:1203-6.
33. Mauillon JL, Michel P, Limacher JM, Latouche JB, Dechelotte P, Charbonnier F, et al. Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer. Cancer Res 1996;56:5728-33.
34. Oefner PJ, Underhill PA. Comparative DNA sequencing by denaturing high-performance liquid chromatography (DHPLC). Am J Hum Genet 1995;57(Suppl):A266.
35. Syngal S, Fox EA, Eng C, Kolodner RD, Garber JE. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MHS2 and MLH1. J Med Genet 2000;37:641-5.